- Home
- RZLV vs OPK Comparison
RZLV vs OPK Comparison
Compare RZLV & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RZLV
- OPK
- Stock Information
- Founded
- RZLV 2016
- OPK 2007
- Country
- RZLV United Kingdom
- OPK United States
- Employees
- RZLV N/A
- OPK N/A
- Industry
- RZLV
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- RZLV
- OPK Health Care
- Exchange
- RZLV NYSE
- OPK Nasdaq
- Market Cap
- RZLV 514.1M
- OPK 1.1B
- IPO Year
- RZLV N/A
- OPK 1995
- Fundamental
- Price
- RZLV $2.42
- OPK $1.34
- Analyst Decision
- RZLV Strong Buy
- OPK Buy
- Analyst Count
- RZLV 5
- OPK 4
- Target Price
- RZLV $5.20
- OPK $2.75
- AVG Volume (30 Days)
- RZLV 11.5M
- OPK 3.3M
- Earning Date
- RZLV 02-21-2025
- OPK 08-06-2025
- Dividend Yield
- RZLV N/A
- OPK N/A
- EPS Growth
- RZLV N/A
- OPK N/A
- EPS
- RZLV N/A
- OPK N/A
- Revenue
- RZLV $187,788.00
- OPK $689,408,000.00
- Revenue This Year
- RZLV $19,894.36
- OPK N/A
- Revenue Next Year
- RZLV N/A
- OPK $6.98
- P/E Ratio
- RZLV N/A
- OPK N/A
- Revenue Growth
- RZLV 29.46
- OPK N/A
- 52 Week Low
- RZLV $1.07
- OPK $1.21
- 52 Week High
- RZLV $12.29
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- RZLV N/A
- OPK 51.42
- Support Level
- RZLV N/A
- OPK $1.32
- Resistance Level
- RZLV N/A
- OPK $1.36
- Average True Range (ATR)
- RZLV 0.00
- OPK 0.04
- MACD
- RZLV 0.00
- OPK 0.00
- Stochastic Oscillator
- RZLV 0.00
- OPK 65.38
About RZLV REZOLVE AI LTD
Rezolve AI PLC is an AI-powered solutions company, specializing in enhancing customer engagement, operational efficiency, and revenue growth for the retail and e-commerce sectors. The company's product, Brain Commerce, powered by its proprietary Large Language Model (LLM) brainpowa, transforms the online shopping experience. By surpassing traditional site search and product discovery tools, Brain Commerce improves conversion rates, increases average order value (AOV), and reduces cart abandonment. The company has one reportable segment, which is cloud-based services. Geographically, the company generates revenue from Canada, the United States, Mexico, Australia, the United Kingdom, and Japan, with the majority of revenue generated from the United States.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.